Equitable Holdings’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Equitable Holdings’s Portfolio SGMO Stock Details SGMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-12,848	Closed	-$5.4K	–	1884
2026 Q1	$5.4K	Buy	+12,848	New	+$5.11K	﹤0.01%	1686

Other funds holding SGMO

NAMI

Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return

AIM

Axiom Investment Management New York $150M AUM

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

HIG

Heritage Investment Group Pompano Beach, Florida $744M AUM 20.51% 1-Year Est. Return

Equitable Holdings's SGMO Position: Q2 2026 in Review

Equitable Holdings sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q2 2026, closing a stake of 12,848 shares — an estimated $5.4K sold.

Equitable Holdings first reported a position in SGMO in Q1 2026 and held it in 1 quarter. The position peaked at $5.4K in Q1 2026. 6 funds tracked by Wall St. Rank hold SGMO as of Q2 2026.

Equitable Holdings reported no remaining SANGAMO THERAPEUTICS INC position as of Q2 2026 after selling out during the quarter.
Equitable Holdings sold 12,848 SANGAMO THERAPEUTICS INC shares in Q2 2026, an estimated $5.4K.
Equitable Holdings first reported a position in SANGAMO THERAPEUTICS INC in Q1 2026 and held it in 1 quarter.
Equitable Holdings's SANGAMO THERAPEUTICS INC position peaked at $5.4K in Q1 2026.
6 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q2 2026.

Based on Equitable Holdings's 13F filing for Q2 2026, filed 17 Aug 2026.